Introduction
============

Urothelial bladder cancer (UBC) is one of the most common malignant tumors of urinary system. UBC can generally be classified into non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), according to whether the cancer cells are restricted locally in the lamina propria or invade the muscularis propria ([@B25]). A great number of studies have reported that according to shared RNA expression patterns or specific genomic alterations MIBC can be further classified into two major subtypes, namely basal and luminal ([@B56]; [@B22]; [@B7],[@B8]; [@B9]; [@B44]; [@B52]), which are strikingly similar to the molecular subtypes first described in breast cancer ([@B49]; [@B50]). The basal subtype has drawn much attention because it is associated with a more aggressive phenotype and has a higher risk of distant metastasis than luminal subtype ([@B7]; [@B52]). One reason for the difference is that the two subtypes develop from etiologically different pathways. Pathways that are involved in EMT and immune-associated pathways are upregulated in the basal subtype ([@B7]). The molecular biomarkers and pathways involved in MIBC subtypes are the key to understanding its subtype heterogeneity and identifying subtype-specific biomarkers that can be used to better manage MIBC patients.

MicroRNAs (miRNAs) represent one of the most exciting areas of modern medical and biological sciences as they can modulate an immense and complex regulatory network of gene expression in a broad spectrum of developmental and cellular processes, such as cell proliferation, metabolism, apoptosis, and viral infection ([@B24]; [@B15]; [@B83]; [@B4]; [@B47]; [@B18]). miRNAs not only have a well-established inhibitory effect on gene expression but also promote gene expression in some cases ([@B54]; [@B61]), and long non-coding RNAs (lncRNAs) exhibit facilitative or suppressive effects on the gene regulatory network during tumor development ([@B14]; [@B64]). Furthermore, aberration or perturbation in miRNA-mediated mRNA and lncRNA expression levels has a significant correlation with serious clinical consequences, including diseases of diverse origins and malignancy ([@B53]; [@B68]; [@B65]; [@B78]; [@B79]; [@B17]).

Regarding molecular drivers of cancer development, oncogenic mutations and downstream signaling pathways in the pre-cancerous or cancerous cell have been thought to play a crucial role in the cancer formation and progression. In addition, recent studies have shown that metabolic reprogramming plays much more important roles than previously thought in cancer development ([@B3]). It is possible that a great number of genomic mutations detected in cancer provide a selective advantage for the cancer cell in the stressful tumor microenvironment by reprogramming cell metabolic processes ([@B80]). No matter what is the primary cause of cancer development, it is clear that both the oncogenic signaling and reprogrammed metabolisms involve numerous genes, working in a concerted manner in a complex network. Gene regulatory network-based view can, therefore, provide a deeper insight into the cancer development.

The aim of this study is to identify subtype-specific dysregulated miRNA-mediated mRNA-lncRNA interactions and discover new critical subtype-related genes in MIBC.

Materials and Methods {#s1}
=====================

Data Acquisition and Pre-processing
-----------------------------------

The MIBC RNA-Seq (FPKM) and clinical data were obtained from The Cancer Genome Atlas (TCGA) public data portal^[1](#fn01){ref-type="fn"}^, and miRNA-Seq (RPM) data was downloaded from the Broad GDAC Firehose^[2](#fn02){ref-type="fn"}^. The gene expression datasets of 403 tumor samples and 19 adjacent normal tissue samples contain 19181 mRNAs, 14376 lncRNAs, and 2588 mature miRNAs. The microarray datasets (GSE32894, GSE13507, and GSE31684) derived from Gene Expression Omnibus (GEO) were used to evaluate the performance of classifiers and verify the prognostic use of marker genes^[3](#fn03){ref-type="fn"}^.

Clustering Analysis and Gene Set Enrichment Analysis
----------------------------------------------------

Consensus clustering ([@B42]) is a method that provides quantitative evidence for determining the number and membership of possible clusters within a dataset, such as RNA-Seq and microarray. For CC analysis, the RPKM gene expression data was pre-processed to detect the most highly expressed and variable genes across samples. We removed 25% genes that have the low arithmetic mean of the given gene across samples. Then the MAD was used to select the most highly expressed and variable 3,000 mRNAs, 300 miRNAs, and 3,000 lncRNAs. CC available in the R package "ConsensusClusterPlus" was performed on 3,000 mRNAs, 300 miRNAs, and 3,000 lncRNAs with 403 tumor samples, using the following key parameters: reps = *50*, innerLinkage = *complete*, clusterAlg = *hc*, k = *6*, and distance = *pearson* ([@B74]).

Cluster of cluster analysis is a method of integrating the primary clustering results into final cluster assignments. Each sample is represented as a binary vector, whose length is ∑ ~i=1~^t^K~i~ (where *t* is the number of datasets and K~i~ is the number of clusters for dataset (*i*), to implement subsequent clustering analysis. We first conducted the CoC analysis on the clustering results of mRNA, miRNA, and lncRNA dataset to obtain a binary dataset. The CC was once more performed on the binary dataset for generating final clusters. Number of final clusters (K) was estimated by commonly used methods including ASW, CPCC, Relative Change in Area under Cumulative density function \[^Δ^(*K*)\], and PAC ([@B86]).

In order to explore subtype-associated biological processes, GSEA ([@B63]) was conducted using three gene set datasets (GO-BP, KEGG, and Hallmark gene sets\]. The following parameters were taken for GSEA: Number of permutations = *1000*, Permutation type = *gene_set*, Enrichment statistic = *weighted*, Metric for ranking genes = *Signal2Noise*.

Differentially Expressed Genes and Machine Learning
---------------------------------------------------

"Ballgown" (R package) was used to identify DEGs between tumor and normal samples ([@B13]). *F*-test was used in "Ballgown", and DEGs here were defined as those with FDR adjusted *p*-value \< 0.05 (Benjamini--Hochberg method) and \|log~2~fold change\| \> 0.57).

Three tree-based machine learning methods, namely DTs, RF, and eXtreme Gradient Boosting (XGBoost or XG), were performed on 3000 mRNAs, 300 miRNAs, and 3000 lncRNAs for MIBC subtype classification. The area under the ROC curve (AUC) was used to estimate the performance of the classification methods. For each classification method, MIBC samples were randomly divided into training (60%) and testing (40%). We performed RF with different parameter values of *ntree* and *mtry*, and used 10-fold cross-validation to acquire the mean accuracy. XGBoost was implemented with the following parameters: gamma = *1*, min_child_weight = *1*, max_depth = *14*, nrounds = *2000*. In order to optimize the parameter *iter* (number of iterations) of XGBoost, we obtained 10-fold cross-validation performance for each *iter* and selected the *iter* value that generated the best performance. For DTs, the following parameters were taken: minCases = 20 and CF = 0.25. Moreover, the well-performed classifiers in this study were trained on the TCGA-derived RNA expression data and were tested on the GSE32894 to further evaluate their performance. All machine learning methods were implemented using R packages including "C5.0", "randomForest", and "XGBoost" packages ([@B34]; [@B5]; [@B28]).

The overlap between the feature genes obtained by the well-performed classifiers and DEGs was referred to as DEFGs. GO enrichment analysis available in the R package "clusterProfiler" was performed on DEFGs to identify their enriched GO terms ([@B77]). A multiple-test correction was done using the method proposed by Benjamini and Hochberg, in which an adjusted *p*-value \< 0.05 was considered to represent statistical significance.

Construction of a Subtype-Related mRNA-miRNA-lncRNA Network
-----------------------------------------------------------

Pairwise Pearson's correlation analysis was carried out on the DEFGs. The lncRNA-miRNA pairs, miRNA-mRNA pairs, and lncRNA-mRNA pairs with \|r\| \> = 0.4 and *p*-value \< 0.05 were considered to be co-expressed gene pairs. If both elements in a co-expressed lncRNA-mRNA pair are simultaneously co-expressed with a miRNA, it is defined as a miRNA-dependent lncRNA-mRNA co-expressed interaction. A miRNA-dependent lncRNA-mRNA network was established using Cytoscape software (version 3.5.1). miRWalk2.0 ([@B11]) is an integration of six widely used databases (miRWalk, miRanda, miRDB, miRNAMap, RNA22, and Targetscan) and supplies the biggest available collection of predicted and experimentally verified miRNA-target interactions. Our inferred co-expressed interactions including mRNA-miRNA and lncRNA-miRNA interactions were compared to those derived from miRWalk2.0. An mRNA is considered to be a true target of miRNA if their interaction occurs in at least four databases, and an lncRNA is considered to be a true target of miRNA if their interaction is supported in at least one database among miRWalk, miRanda, and Targetscan.

Survival Analysis
-----------------

We further assessed whether the genes in the inferred interactions are correlated with the overall survival of MIBC patients. Based on the mean expression level of the genes, patient samples were divided into high and low expression groups. We performed survival analysis available in R package "survival" ([@B66]) using the Kaplan--Meier curve (K--M curve) method. A log-rank test was used to compare survival times between two groups, and *p* \< 0.05 was considered to represent the statistical significance.

Results
=======

Clustering Analysis and GSEA
----------------------------

We first performed the CC on mRNA, miRNA, and lncRNA expression datasets to obtain the clustering results. By applying the CoC analysis to the clustering outcomes of CC, a binary dataset was obtained, which was referred to as CoC dataset. The CC was once again performed on the CoC dataset to generate the different Ks, and the ASW, CPCC, Δ*K*, and PAC were used to evaluate the optimal K (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). As a result, for the CoC dataset, ASW evaluation suggests the optimal K of 6 and CPCC, Δ*K*, and PAC indicate the optimal *K* of 2. Given that *K* = 2 is the consistent optimal value, we chose *K* = 2 as a solution, dividing MIBC samples into two subtypes, namely subtype-1 and subtype-2. The hierarchically clustered heatmap of *K* = 2 for CoC dataset was shown in **Figure [1A](#F1){ref-type="fig"}**. Survival curves regarding two subtypes were plotted using the K-M method. Our results have shown that 5-year overall survival rate with regard to subtype-1 is 55% and 30% for subtype-2, indicating that they differ considerably in clinical prognosis (**Figure [1B](#F1){ref-type="fig"}**, *p* \< 0.01). The heatmap depicting basal biomarkers, luminal biomarkers, and clinical indicators for the two subtypes was shown in the **Figure [1C](#F1){ref-type="fig"}**. The subtype-1 is characterized by the high expression of luminal markers such as CYP2J2, ERBB2, and KRT18, while the subtype 2 is characterized by high expression of basal markers such as CD44, CDH3, and KRT1. The Pearson's chi-squared test is utilized to compare clinical indicators between the two subtypes. The histology, stage, grade, and status are significantly different between the two subtypes, and gender almost differs between the two subtypes (**Supplementary Table [S1](#SM6){ref-type="supplementary-material"}**). The subtype-1 and subtype-2 resemble the luminal and basal subtype, respectively, in terms of K--M curves, biomarkers, and clinical indicators, therefore, which were redefined as luminal and basal subtypes ([@B7]).

![Subtype-1 and subtype-2 Classification for MIBC. **(A)** Hierarchically clustered heatmap for CoC dataset (*K* = 2). **(B)** A K-M plot for overall 5-year survival of subtype-1 and subtype-2 (subtype-1 = 193, subtype-2 = 210, *p* \< 0.01). **(C)** Heatmap depicts the expression profiles of basal (up) and luminal (down) biomarkers in subtype-1 and subtype-2. Covariate annotation tracks show selected clinical features. The yellow and turquoise colors correspond to high and low relative expression, respectively.](fgene-09-00422-g001){#F1}

Gene set enrichment analysis was done for the basal and luminal subtypes, and the results were shown in **Tables [1](#T1){ref-type="table"}**, **[2](#T2){ref-type="table"}**. Upregulated pathways in luminal subtype are mainly involved in metabolism (e.g., oxidative phosphorylation, cytochrome P450, and fatty acid metabolism) (**Table [1](#T1){ref-type="table"}**). Whereas, upregulated pathways in the basal subtype are principally related to immune system process (e.g., extracellular structure organization, allograft rejection, mTORC1 signaling, and TNF-a signaling via NF-kB), metastasis, and EMT (**Table [2](#T2){ref-type="table"}**).

###### 

Top-ranked terms of GO-BP, KEGG and Hallmark gene sets for the luminal subtype.

  Gene set name                                                       Size   NES      FDR *q*-value
  ------------------------------------------------------------------- ------ -------- ---------------
  **GO-BP**                                                                           
  GO monocarboxylic acid catabolic process                            95     2.5151   0
  GO oxidative phosphorylation                                        73     2.4333   0
  GO fatty acid catabolic process                                     80     2.4284   0
  GO fatty acid beta oxidation                                        51     2.3211   0
  GO electron transport chain                                         78     2.3116   0
  GO organic acid catabolic process                                   92     2.2781   2.26E-04
  GO mitochondrial respiratory chain complex assembly                 42     2.1788   0.0014
  GO lipid oxidation                                                  63     2.1586   0.0015
  GO mitochondrial respiratory chain complex i biogenesis             199    2.1449   0.0018
  GO establishment of protein localization to endoplasmic reticulum   70     2.1285   0.0022
  **KEGG**                                                                            
  KEGG ribosome                                                       87     2.3289   0
  KEGG alpha linolenic acid metabolism                                19     2.0770   5.29E-04
  KEGG metabolism of xenobiotics by cytochrome p450                   68     2.0424   5.36E-04
  KEGG valine leucine and isoleucine degradation                      44     1.9767   0.00137
  KEGG drug metabolism cytochrome p450                                70     1.9727   0.00120
  KEGG oxidative phosphorylation                                      116    1.9372   0.00209
  KEGG peroxisome                                                     78     1.9320   0.00214
  KEGG fatty acid metabolism                                          42     1.9184   0.00229
  KEGG retinol metabolism                                             63     1.8697   0.00391
  KEGG linoleic acid metabolism                                       29     1.8393   0.00482
  **Hallmark gene sets**                                                              
  Hallmark oxidative phosphorylation                                  198    1.5145   0.05830
  Hallmark bile acid metabolism                                       112    1.4110   0.07668
  Hallmark peroxisome                                                 103    1.4095   0.05174
  Hallmark adipogenesis                                               191    1.3794   0.05125
  Hallmark fatty acid metabolism                                      156    1.2596   0.11892
                                                                                      

NES, normalized enrichment score; GO-BP, Gene Ontology Biological Process; KEGG, Kyoto Encyclopedia of Genes and Genomes. Size is the number of genes in the gene set. A positive NES means that genes over-represented in the gene set are upregulated in luminal subtypes.

###### 

Top-ranked categories of GO-BP, KEGG and Hallmark gene sets for the basal subtype.

  Gene set name                                                                         Size   NES        FDR *q*-value
  ------------------------------------------------------------------------------------- ------ ---------- ---------------
  **GO-BP**                                                                                               
  GO extracellular structure organization                                               297    --2.8256   0
  GO antigen processing and presentation of exogenous peptide antigen via mhc class i   65     --2.7258   0
  GO antigen processing and presentation                                                206    --2.6334   0
  GO antigen processing and presentation of peptide antigen                             170    --2.6246   0
  GO antigen processing and presentation of peptide antigen via mhc class i             90     --2.6134   0
  GO chondroitin sulfate biosynthetic process                                           25     --2.6008   0
  GO collagen fibril organization                                                       36     --2.5958   0
  GO regulation of innate immune response                                               349    --2.5825   0
  GO positive regulation of defense response                                            360    --2.5802   0
  GO cytokine mediated signaling pathway                                                440    --2.5675   0
  **KEGG**                                                                                                
  KEGG focal adhesion                                                                   197    --2.6862   0
  KEGG cytokine cytokine receptor interaction                                           257    --2.5127   0
  KEGG ecm receptor interaction                                                         84     --2.512    0
  KEGG proteasome                                                                       43     --2.4802   0
  KEGG leishmania infection                                                             69     --2.4718   0
  KEGG viral myocarditis                                                                68     --2.4178   0
  KEGG hematopoietic cell lineage                                                       85     --2.4134   0
  KEGG regulation of actin cytoskeleton                                                 211    --2.3911   0
  KEGG allograft rejection                                                              35     --2.3902   0
  KEGG autoimmune thyroid disease                                                       50     --2.3778   0
  **Hallmark gene sets**                                                                                  
  Hallmark epithelial-mesenchymal transition                                            197    --3.2473   0
  Hallmark inflammatory response                                                        197    --3.0190   0
  Hallmark interferon gamma response                                                    197    --2.9964   0
  Hallmark interferon alpha response                                                    94     --2.9491   0
  Hallmark allograft rejection                                                          199    --2.9010   0
  Hallmark G2M checkpoint                                                               194    --2.6389   0
  Hallmark E2F targets                                                                  196    --2.6177   0
  Hallmark TNF-a signaling via NF-kB                                                    198    --2.5512   0
  Hallmark complement                                                                   195    --2.5475   0
  Hallmark mTORC1 signaling                                                             198    --2.441    0
                                                                                                          

All abbreviations are the same as in

Table

1

. A negative NES value indicates that genes over-represented in the gene set are upregulated in the basal subtype.

Differentially Expressed Genes and Machine Learning
---------------------------------------------------

The DEGs that could distinguish tumor from normal samples were analyzed and visualized as volcano plots (**Supplementary Figures [S2A--C](#SM2){ref-type="supplementary-material"}**). In total, 208 miRNAs (148 upregulated and 60 downregulated), 2488 lncRNAs (1402 upregulated and 1086 down-regulated), and 4167 mRNAs (2314 upregulated and 1853 downregulated) are differentially expressed.

We applied DTs, RF, and XGBoost for the basal and luminal subtype classification based on mRNA, miRNA, and lncRNA expression dataset, and AUC was used to evaluate their performance. As shown in **Figure [2A](#F2){ref-type="fig"}**, XGBoost outperforms RF and DTs, having AUC values of 98.6, 94.5, and 98.7%, respectively, in mRNA, miRNA and lncRNA-based classification. Details regarding 10-fold cross-validation procedure can be found in **Supplementary Figure [S3](#SM3){ref-type="supplementary-material"}**. DTs was excluded in the following comparison, as it is significantly inferior to RF and XG on average. By using the CC method, the GSE32894 dataset containing 28 biomarkers and 190 samples was grouped into two subtypes prepared for the classification task. The heatmap plots and the K--M curves for the two subtypes were shown in **Supplementary Figure [S4](#SM4){ref-type="supplementary-material"}**. We trained the well-performed classifiers (RF and XG) on mRNA dataset that was derived from TCGA and tested them on GSE32894 dataset. The results demonstrated that XGBoost has a better performance than RF (**Figure [2A4](#F2){ref-type="fig"}**).

![ROC curves for classification predictors and information for differentially expressed feature genes (DEFGs). **(A)** ROC curves for XGBoost, RF, and DTs classifiers in mRNA, miRNA, lncRNA, and GSE32894 dataset. **(B)** An UpSet plot for intersected information between DEGs and the feature genes obtained by XGBoost and RF. **(C)** A Circos plot for 278 DEFmRNAs with gene symbols, chromosomal cytobands, and other information. From inside to outside, variable weight from RF (brown), fold change from DEGs (up in red, down in green), *p*-value from univariate Cox's proportional regression analysis (*p* \> 0.05 in red, *p* \< 0.05 in brown), DEFlncRNAs (coral), DEFmiRNAs (deep pink), DEFmRNAs (red). **(D)** Bubble plots for enriched GO terms generated from 278 DEFmRNAs. The *x*-axis represents the --log~10~(*p*-value) of each term and the *y*-axis represents the number of genes in each term.](fgene-09-00422-g002){#F2}

The intersection between DEGs and feature genes obtained by RF and XG was defined as DEFGs, which includes 57 lncRNAs, 120 miRNAs, and 278 mRNAs. The Upset plot and heatmap plots for DEFGs were shown in **Figure [2B](#F2){ref-type="fig"}** and **Supplementary Figures [S2D--F](#SM2){ref-type="supplementary-material"}**. The genetic and clinical information of DEFGs was visualized in **Figure [2C](#F2){ref-type="fig"}**. GO enrichment analysis indicated that differentially expressed feature mRNAs are enriched with adherens junction, cell-substrate junction, cell-cell junction, cell-substrate adherens junction, and focal adhesion (**Figure [2D](#F2){ref-type="fig"}**). These GO terms have been found to play roles in tumorigenesis and tumor progression by regulating T-cell signaling, innate immunity, TGF-β signaling, and Wnt signaling through post-translational modification ([@B26]; [@B37]; [@B35]; [@B6]; [@B29]).

Construction of Subtype-Related mRNA-miRNA-lncRNA Network
---------------------------------------------------------

A miRNA-dependent mRNA-lncRNA co-expression network was constructed, which consists of 90 mRNAs, 22 miRNAs, and 14 lncRNAs (**Figure [3A](#F3){ref-type="fig"}**). The miRNA-dependent mRNA-lncRNA crosstalks verified in miRWalk database contain four miRNA-mediated mRNA-lncRNA interactions (**Figure [3B](#F3){ref-type="fig"}**). To be specific, two co-expressed lncRNA-mRNA pairs, AC010326.3-GATA3 and AC073335.2-GATA3, are positively regulated by miR-141-3p; The lncRNA-mRNA pairs, such as MIR100HG--CLIC4 and MIR100HG--PALLD, are negatively regulated by miR-200c-3p and miR-141-5p, respectively. All the nine genes in the network differ in their expression between the two subtypes (**Figure [3C](#F3){ref-type="fig"}**). For instance, as compared to the luminal subtype, the basal subtype is characterized by a lower expression level of six genes (miR-200c-3p, miR-141-3p, miR-141-5p, GATA3, AC010326.3, and AC073335.2) and a higher expression level of the other three genes (MIR100HG, PALLD, and CLIC4), suggesting that all the nine genes can be used as potential markers for the two MIBC subtypes. In addition, GO analysis showed that the mRNAs in the network (CLIC4, PALLD, and GATA3) are related to cytoskeleton.

![Subtype-related miRNA-dependent mRNA-miRNA interactions. **(A)** The co-expression network for miRNA-mediated mRNA-lncRNA interactions. The crimson nodes represent miRNAs, the green nodes represent lncRNAs, and the sky blue nodes represent mRNAs. **(B)** miRNA-mediated mRNA-lncRNA interactions validated by mirWalk 2.0. The green color represents downregulation in tumor compared with normal sample whereas the yellow color corresponds to upregulation in the tumor. The blue lines represent positive correlations and black lines represent negative correlations. **(C)** The heatmap depicts the expression level of nine DEFGs in basal and luminal subtypes. The yellow and turquoise colors correspond to high and low relative expression, respectively. Original expression value was log2 transformed.](fgene-09-00422-g003){#F3}

Survival Analysis of Crosstalk-Involved Genes
---------------------------------------------

The association between expression levels of crosstalk-involved genes and MIBC prognosis was analyzed by K--M method. Strikingly, the results revealed that all of them are closely related to prognosis of MIBC. Specifically, the higher expression level of miR-141-5p, miR-141-3p, AC010326.3, AC073335.2, miR-200c-3p, and GATA3 predicts better prognosis, indicating that they may function as tumor suppressors (**Figures [4B--F,H](#F4){ref-type="fig"}**); In contrast, the higher expression level of MIR100HG, PALLD, and CLIC4 is associated with worse prognosis, suggesting that they may play an oncogenic role (**Figures [4A,G,I](#F4){ref-type="fig"}**). In addition, the association between MIBC prognosis and expression levels of crosstalk-related mRNAs (CLIC4, PALLD, and GATA3) was validated in two independent microarray datasets (GSE13507 and GSE31684), suggesting again their prognosis value in MIBC (**Supplementary Figure [S5](#SM5){ref-type="supplementary-material"}**).

![Kaplan--Meier plots for crosstalk-involved genes. **(A--I)** The red lines represent the high expression of crosstalk-involved genes while blue lines represent the corresponding low expression. The *p*-value was calculated using a log-rank test, where *p* \< 0.05 represents statistical significance.](fgene-09-00422-g004){#F4}

Discussion
==========

In this study, we have investigated miRNA-dependent mRNA-lncRNA interactions in MIBC basal and luminal subtypes using bioinformatics approaches. On the basis of MIBC mRNA, miRNA, and lncRNA expression datasets obtained from TCGA, 403 MIBC samples were reliably classified into two intrinsic molecular types, which resemble basal and luminal subtypes identified previously ([@B7]). A number of subtype-related pathways were identified through GSEA. Moreover, we conducted and compared subtype classification performance among tree-based machine learning algorithms, and found XGBoost outperforms other classifiers. Additionally, we implemented a gene co-expression analysis on DEFGs and successfully identified subtype-specific mRNA-lncRNA crosstalks, which differ considerably between basal and luminal subtypes and have close relationships with the prognosis of MIBC.

Subtype-related pathways presented in this study (**Tables [1](#T1){ref-type="table"}**, **[2](#T2){ref-type="table"}**) are largely consistent with the previously identified ([@B7]; [@B20]; [@B40]; [@B45]; [@B16]; [@B55]; [@B1]). In general, pathways that are involved in the EMT, metastasis, and immune system process, are upregulated in the basal subtype, whereas, metabolic-related pathways are upregulated in the luminal subtype. Th pathways enriched in basal and luminal subtypes provide a biological explanation for their distinctively different clinical and pathological behaviors. However, the mechanisms by which some other pathways shown in our results, like valine leucine, isoleucine degradation, autoimmune thyroid disease, hematopoietic cell lineage and viral myocarditis, play a role in MIBC subtypes deserve further investigation.

Many machine learning methods have been broadly applied in many areas of biology such as gene family classification, hepatotoxicity prediction, RNA methylation prediction, cancer prediction and classification ([@B85]; [@B27]; [@B33], [@B32]; [@B62]; [@B70],[@B71]). As suggested in previous studies, RF is a powerful classifier for classifying gene expression data ([@B75]; [@B30]; [@B21]). And XGBoost keeps winning in "every" Kaggle competition and has become a really popular tool among data scientists ([@B51]; [@B67]; [@B82]). Recently, XGBoost has been successfully applied to many classification problems, such as pan-cancer classification ([@B31]) and prediction of RNA-protein interactions ([@B23]). However, no comparison between RF and XGBoost in terms of cancer classification has been made in the past. In this study, we compared the performance of DTs, RF, XGBoost in classifying basal and luminal subtypes. Our results clearly demonstrated the advantage of XGBoost in gene expression data-based cancer classification (**Figure [2A](#F2){ref-type="fig"}**).

Previous studies investigated MIBC-associated miRNAs and their target genes without considering the genetic heterogeneity of MIBC subtypes ([@B39]; [@B19]; [@B76]; [@B84]). It is therefore important to elucidate the subtype-related molecular pathways and identify novel biomarkers for MIBC subtypes. In this study, we systematically explored MIBC subtype-related gene co-expression networks. A total of three mRNAs (GATA3, CLIC4, and PALLD), three miRNAs (miR-200c-3p, miR-141-3p, and miR-141-5p), and three lncRNAs (AC010326.3, AC073335.2, and MIR100HG) were found in miRNA-mediated mRNA-lncRNA crosstalks, which differ considerably in their expression between basal and luminal subtypes (**Figure [3](#F3){ref-type="fig"}**), and their expression level is significantly associated with the prognosis of MIBC (**Figure [4](#F4){ref-type="fig"}**). It was previously observed that miR-141-5p, miR-141-3p, miR-200c-3p, and GATA3 are the most important markers of luminal subtype, which is consistent with our results ([@B52]). Besides, previous studies found that the down-regulation of miR-200c and miR-141 is associated with elevated ZEB1 ([@B73]; [@B57]; [@B38]), and the down-regulation of miR-200c is also coupled with the down-regulation of BMI-1 and E2F3 ([@B36]), which play an important role in the invasion, migration, and EMT of bladder cancer.

It has been shown that some other genes in the crosstalk are also closely related to cancer. For example, AC073335.2, a highly expressed lncRNA in human glioblastoma, is involved in tumorigenesis via acting as a competing endogenous RNA of miR-940 ([@B59]). MIR100HG was previously reported to act as a regulator of hematopoiesis and oncogenes in many cancers ([@B12]; [@B43]; [@B58]; [@B72]; [@B81]). In agreement with our findings, MIR100HG was reported to be down-regulated in MIBC and may serve as a significant biomarker for MIBC ([@B69]). As reported previously, GATA3 is a prognostic marker and inhibits cell migration and invasion in MIBC ([@B41]; [@B7],[@B8]). And, GATA3 is differentially expressed between basal and luminal subtypes and can be used as a luminal-infiltrated marker ([@B52]). CLIC4 has a complicated role in cancer. For instance, it functions as a tumor suppressor in lung adenocarcinomas ([@B46]). And it promotes the metastasis and development of colorectal cancer ([@B10]; [@B48]). Previous studies have established that the expression of CLIC4 in MIBC has a subtype-dependent pattern ([@B52]). And the overexpression of CLIC4 in stroma increases cell migration and invasion and promotes epithelial to mesenchymal transition in multiple human cancers ([@B60]). PALLD SNPs were reported to be a significant predictor of prostate cancer-specific mortality ([@B2]). Our findings are largely consistent with previously reported results, suggesting crosstalk-implicated genes might be of great significance in MIBC pathogenesis and post-transcriptional gene regulation.

The combination of bioinformatics and several machine learning approaches in this study have achieved reliable results regarding the MIBC subtype classification, subtype-associated pathways, and the network-associated markers for MIBC subtypes. The subtype-related genes can not only be used for subtype classification but also serve as a good predictor of cancer prognosis. It is worth noting that we can enhance our study in the following aspects in the future: (1) the crosstalks discovered through computational analyses need to be verified by biological experiments. (2) DEFGs were defined as the overlap between DEGs and feature genes that were determined by XGBoost based on the ranking approximates of Information Gain. This procedure may result in the missing of some highly correlated genes that are also biologically important.

Conclusion
==========

By conducting bioinformatics analyses, we identified two subtypes of MIBC and lncRNA-mRNA crosstalks mediated by miR-200c and miR-141, which are found to be significantly associated with prognosis, formation, and metastasis of bladder cancer. Our results should be informative for molecular subtype classification, prognosis and molecule-targeted therapy of bladder cancer.
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###### 

The graphs show the evaluation output of ACW, CPCC, Δ*K*, and PAC. CoC datasets represented by green line were used as the criteria to infer optimal K. **(A)** ASW allows us to inference the optimal K by high ASW. **(B)** The optimal K according to CPCC is that the magnitude of CPCC should be very close to one. **(C)** The optimal K according to Δ*K* is the *K* value before the 'elbow' or the K where D(K) reaches its maximum. **(D)** PAC allows us to inference the optimal K by the lowest PAC.

###### 

Click here for additional data file.

###### 

Volcano plots for DEGs and heatmap plots for DEFGs. **(A--C)** Volcano plots for differentially expressed 4167 mRNAs, 208 miRNAs, and 2488 lncRNAs between tumor and normal samples (adjusted *p*-value \< 0.05 and \|log~2~fold change\| \> 0.57). **(D--F)** Heatmap plots for 278 DEFmRNAs, 120 DEFmiRNAs, and 57 DEFlncRNAs. Basal, luminal, and normal samples are represented by the red, blue, and yellow bar, respectively.

###### 

Click here for additional data file.

###### 

Parameter selection and Performance of RF and XG in mRNA, miRNA and lncRNA dataset. **(A)** The *x*-axis represents the number of mtry set for RF classifier (1, 5, 10, 15, 20, 25). The *y*-axis represents the corresponding AUC. **(B)** The *x*-axis represents the number of ntree set for RF (20, 400, 600, 800). The *y*-axis represents corresponding obb error rates. The colors correspond to mtry numbers. **(C)** The x-axis represents the number of fold set for RF. The *y*-axis represents corresponding accuracy. The red color shows mean accuracy. **(D)** The *x*-axis represents the number of *iter* set for XG (1, 400, 800, 1200, 1600, 2000, 2400) and the y-axis represents the corresponding accuracy.

###### 

Click here for additional data file.

###### 

Heatmap and K--M plots for basal and luminal subtypes of GSE32894. **(A)** Heatmap depicts the expression profiles of basal (up) and luminal (down) biomarkers in GSE32894. The yellow and turquoise color corresponds to high and low relative expression, respectively. **B**. A K-M plot for the overall 5-year survival of basal and luminal subtypes (basal = 52, luminal = 62, *p* \< 0.01).
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Click here for additional data file.

###### 

Kaplan-Meier plots for CLIC4, PALLD, and GATA3 in GSE13507 and GSE31684. **(A--C)** K--M survival curves showing overall survival according to high expression and low expression of CLIC4, PALLD, and GATA3 in GSE13507. **(D--F)** K--M survival curves showing overall survival according to high expression and low expression of CLIC4, PALLD, GATA3, and MIR100HG in GSE31684.

###### 

Click here for additional data file.

###### 

Click here for additional data file.

ASW

:   Average of Silhouette Width

CC

:   cellular component

CC

:   consensus clustering

CDF

:   cumulative density function

CoC

:   cluster of cluster

CPCC

:   cophenetic correlation coefficient

DEFGs

:   differentially expressed feature genes

DEGs

:   differentially expressed genes

DTs

:   decision trees

EMT

:   epithelial-mesenchymal transition

FDR

:   False Discovery Rate

GO-BP

:   Gene Ontology Biological Process

GSEA

:   gene set enrichment analysis

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

K--M curve

:   Kaplan--Meier curve

MAD

:   median absolute deviation

MF

:   molecular function

MIBC

:   muscle-invasive bladder cancer

NES

:   normalized enrichment scores

PAC

:   proportion of ambiguous clustering

RF

:   random forest

ROC

:   receiver operating characteristics curve

XGBoost

:   eXtreme Gradient Boosting
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